Content about pharma

FTC issues warnings on 'junk' patent listings for Ozempic and other drugs (statnews.com)

I don't know what a "patent listing" is, at least in the context of "patent filings" as mentioned in this article, but I do know that we already have ways for dealing with "junk" patent applications - the patentability requirements of existing law. If those aren't met, a patent the USPTO shouldn't issue a patent. If the Office needs more resources to better analyze "patent listings" or "patent filings" (I assume both refer to "patent applications"), then give the Congress needs to increase funding for the Office.

It's a question of resources, not rules.

tags: patents pharma

posted by matt in Tuesday, April 30, 2024

Pfizer to allow generic versions of its Covid-19 pill in 95 countries (cnbc.com)

This is a smart move by Pfizer (and Merck, which was first to make the arrangement for an oral antiviral pill for Covid). It's smart patent strategy, and also the right thing to do.

tags: covid pharma patents

posted by matt in Tuesday, November 16, 2021